Thursday, February 02, 2017

Company Says It Gave Price Exclusive Stock Deal, Contrary To His Testimony

Matt Shuham · Monday, January 30, 2017, 4:18 pm

An Australian pharmaceutical company says it gave President Donald Trump’s nominee to lead the Department of Health and Human Services an exclusive deal to purchase stock, the Wall Street Journal reported Monday.

That directly contradicts Price's testimony in his confirmation hearings that discounted shares of Innate Immunotherapeutics Ltd. “were available to every single individual that was an investor at the time."

Read more

No comments: